drugset / Trial / NCT02580708
Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and anti-tumor effect of rociletinib when administered in combination with trametinib.
Timeline
- Start
- 2015-09-30
- Primary completion
- 2016-05-05
- Completion
- 2016-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rociletinib | Small molecule | — | — |
| Subject | Trametinib | Small molecule | — | — |